Clinical Application of Anti-Carcinoma Human Monoclonal Antibody View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1998

AUTHORS

Keiji Koda , Mark C. Glassy , Nobuyuki Nakajima

ABSTRACT

A human monoclonal antibody SKI (HuMAb SKI) recognizes a 42-46 KDa sialoglycoprotein which is commonly expressed on carcinoma tissues. In order to examine the in vivo accumulation capacity of SKI, immunoscintigraphy was performed in colorectal cancer patients. Under informed consent, 4 patients with suspected recurrent colorectal cancers were entered into the study. On day 1, l-2mg of biotinylated SKI was administered intravenously to each patient. On day 2, 5mg of streptavidin was administered, followed one day later, biotinylated 111InCl3 was administered. Either planar or SPECT (single photon emission tomography) images were obtained 6 to 24 hours later. Two cases out of three histologically-proven local pelvic recurrences were successfully imaged with this protocol. One case who had been diagnosed as local recurrence by a computed tomography (CT), and a magnetic resonance imaging (MRI) was true-negative in immunoscintigraphy. No side effects were observed. These findings suggested that HuMAb SK1 effectively accumulates to the tumor regions in vivo. In addition, it was also suggested that immunoscintigraphy using SK1 is a safe and an effective approach for the detection of local recurrence of rectal cancers. More... »

PAGES

161-164

References to SciGraph publications

Book

TITLE

Animal Cell Technology: Basic & Applied Aspects

ISBN

978-94-010-6170-4
978-94-011-5161-0

Author Affiliations

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-94-011-5161-0_28

DOI

http://dx.doi.org/10.1007/978-94-011-5161-0_28

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1053644903


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Chiba University", 
          "id": "https://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "First Department of Surgery, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-Ku 260, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koda", 
        "givenName": "Keiji", 
        "id": "sg:person.0647155176.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647155176.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Novopharm Biotech, Inc., 6190 Cornerstone Court E., Ste. 106, 92121, San Diego, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Glassy", 
        "givenName": "Mark C.", 
        "id": "sg:person.01005621065.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005621065.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chiba University", 
          "id": "https://www.grid.ac/institutes/grid.136304.3", 
          "name": [
            "First Department of Surgery, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-Ku 260, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakajima", 
        "givenName": "Nobuyuki", 
        "id": "sg:person.0712131445.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712131445.60"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1073/pnas.80.20.6327", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019673515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archsurg.1990.01410240073015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027477712"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02052265", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028423483", 
          "https://doi.org/10.1007/bf02052265"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1007/bf02052265", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028423483"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1007/bf02052265", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028423483"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077881267", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082807375", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998", 
    "datePublishedReg": "1998-01-01", 
    "description": "A human monoclonal antibody SKI (HuMAb SKI) recognizes a 42-46 KDa sialoglycoprotein which is commonly expressed on carcinoma tissues. In order to examine the in vivo accumulation capacity of SKI, immunoscintigraphy was performed in colorectal cancer patients. Under informed consent, 4 patients with suspected recurrent colorectal cancers were entered into the study. On day 1, l-2mg of biotinylated SKI was administered intravenously to each patient. On day 2, 5mg of streptavidin was administered, followed one day later, biotinylated 111InCl3 was administered. Either planar or SPECT (single photon emission tomography) images were obtained 6 to 24 hours later. Two cases out of three histologically-proven local pelvic recurrences were successfully imaged with this protocol. One case who had been diagnosed as local recurrence by a computed tomography (CT), and a magnetic resonance imaging (MRI) was true-negative in immunoscintigraphy. No side effects were observed. These findings suggested that HuMAb SK1 effectively accumulates to the tumor regions in vivo. In addition, it was also suggested that immunoscintigraphy using SK1 is a safe and an effective approach for the detection of local recurrence of rectal cancers.", 
    "editor": [
      {
        "familyName": "Nagai", 
        "givenName": "K.", 
        "type": "Person"
      }, 
      {
        "familyName": "Wachi", 
        "givenName": "M.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-94-011-5161-0_28", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-94-010-6170-4", 
        "978-94-011-5161-0"
      ], 
      "name": "Animal Cell Technology: Basic & Applied Aspects", 
      "type": "Book"
    }, 
    "name": "Clinical Application of Anti-Carcinoma Human Monoclonal Antibody", 
    "pagination": "161-164", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1053644903"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-94-011-5161-0_28"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "ff8492bc43eb41bb5ccf01ed5be052cdeece0c122c83e3af63b55fd7187de43e"
        ]
      }
    ], 
    "publisher": {
      "location": "Dordrecht", 
      "name": "Springer Netherlands", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-94-011-5161-0_28", 
      "https://app.dimensions.ai/details/publication/pub.1053644903"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T09:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130811_00000004.jsonl", 
    "type": "Chapter", 
    "url": "https://link.springer.com/10.1007%2F978-94-011-5161-0_28"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-94-011-5161-0_28'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-94-011-5161-0_28'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-94-011-5161-0_28'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-94-011-5161-0_28'


 

This table displays all metadata directly associated to this object as RDF triples.

103 TRIPLES      23 PREDICATES      33 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-94-011-5161-0_28 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N6156c0d51340479f8584c80a12664bc4
4 schema:citation sg:pub.10.1007/bf02052265
5 https://app.dimensions.ai/details/publication/pub.1077881267
6 https://app.dimensions.ai/details/publication/pub.1082807375
7 https://doi.org/10.1001/archsurg.1990.01410240073015
8 https://doi.org/10.1007/bf02052265
9 https://doi.org/10.1073/pnas.80.20.6327
10 schema:datePublished 1998
11 schema:datePublishedReg 1998-01-01
12 schema:description A human monoclonal antibody SKI (HuMAb SKI) recognizes a 42-46 KDa sialoglycoprotein which is commonly expressed on carcinoma tissues. In order to examine the in vivo accumulation capacity of SKI, immunoscintigraphy was performed in colorectal cancer patients. Under informed consent, 4 patients with suspected recurrent colorectal cancers were entered into the study. On day 1, l-2mg of biotinylated SKI was administered intravenously to each patient. On day 2, 5mg of streptavidin was administered, followed one day later, biotinylated 111InCl3 was administered. Either planar or SPECT (single photon emission tomography) images were obtained 6 to 24 hours later. Two cases out of three histologically-proven local pelvic recurrences were successfully imaged with this protocol. One case who had been diagnosed as local recurrence by a computed tomography (CT), and a magnetic resonance imaging (MRI) was true-negative in immunoscintigraphy. No side effects were observed. These findings suggested that HuMAb SK1 effectively accumulates to the tumor regions in vivo. In addition, it was also suggested that immunoscintigraphy using SK1 is a safe and an effective approach for the detection of local recurrence of rectal cancers.
13 schema:editor Ned2816effdab408dbb46a5f4ac46086a
14 schema:genre chapter
15 schema:inLanguage en
16 schema:isAccessibleForFree false
17 schema:isPartOf Na47a2e80f18e40b09a1fc4f1d26fd3b3
18 schema:name Clinical Application of Anti-Carcinoma Human Monoclonal Antibody
19 schema:pagination 161-164
20 schema:productId N53f48d10c0d54ee5878abbd5f7c240f6
21 Nc7d3822375004c2997aae2ce57e9bedc
22 Ne3e9925f84ad4b888d863230e0a94135
23 schema:publisher N8cc24005f6f142ad8cbcd7a73fa2921c
24 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053644903
25 https://doi.org/10.1007/978-94-011-5161-0_28
26 schema:sdDatePublished 2019-04-16T09:16
27 schema:sdLicense https://scigraph.springernature.com/explorer/license/
28 schema:sdPublisher N11ee926bf81e416587d72133d8cf71bc
29 schema:url https://link.springer.com/10.1007%2F978-94-011-5161-0_28
30 sgo:license sg:explorer/license/
31 sgo:sdDataset chapters
32 rdf:type schema:Chapter
33 N0ac8eabe2a3f4f6591342d14a59d7f1e rdf:first sg:person.0712131445.60
34 rdf:rest rdf:nil
35 N11ee926bf81e416587d72133d8cf71bc schema:name Springer Nature - SN SciGraph project
36 rdf:type schema:Organization
37 N143977ff053c4264be9b11a6aab2337a rdf:first sg:person.01005621065.14
38 rdf:rest N0ac8eabe2a3f4f6591342d14a59d7f1e
39 N380500bf00e2497598ace8de91f851eb schema:name Novopharm Biotech, Inc., 6190 Cornerstone Court E., Ste. 106, 92121, San Diego, CA, USA
40 rdf:type schema:Organization
41 N53f48d10c0d54ee5878abbd5f7c240f6 schema:name dimensions_id
42 schema:value pub.1053644903
43 rdf:type schema:PropertyValue
44 N6156c0d51340479f8584c80a12664bc4 rdf:first sg:person.0647155176.80
45 rdf:rest N143977ff053c4264be9b11a6aab2337a
46 N8cc24005f6f142ad8cbcd7a73fa2921c schema:location Dordrecht
47 schema:name Springer Netherlands
48 rdf:type schema:Organisation
49 Na47a2e80f18e40b09a1fc4f1d26fd3b3 schema:isbn 978-94-010-6170-4
50 978-94-011-5161-0
51 schema:name Animal Cell Technology: Basic & Applied Aspects
52 rdf:type schema:Book
53 Nb5d2de33bc4f40409157af45114e2687 rdf:first Nd144090fc904468dbacf97c456674c51
54 rdf:rest rdf:nil
55 Nc1c8315d2b394f1a9d1a69343b34ec76 schema:familyName Nagai
56 schema:givenName K.
57 rdf:type schema:Person
58 Nc7d3822375004c2997aae2ce57e9bedc schema:name doi
59 schema:value 10.1007/978-94-011-5161-0_28
60 rdf:type schema:PropertyValue
61 Nd144090fc904468dbacf97c456674c51 schema:familyName Wachi
62 schema:givenName M.
63 rdf:type schema:Person
64 Ne3e9925f84ad4b888d863230e0a94135 schema:name readcube_id
65 schema:value ff8492bc43eb41bb5ccf01ed5be052cdeece0c122c83e3af63b55fd7187de43e
66 rdf:type schema:PropertyValue
67 Ned2816effdab408dbb46a5f4ac46086a rdf:first Nc1c8315d2b394f1a9d1a69343b34ec76
68 rdf:rest Nb5d2de33bc4f40409157af45114e2687
69 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
70 schema:name Medical and Health Sciences
71 rdf:type schema:DefinedTerm
72 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
73 schema:name Oncology and Carcinogenesis
74 rdf:type schema:DefinedTerm
75 sg:person.01005621065.14 schema:affiliation N380500bf00e2497598ace8de91f851eb
76 schema:familyName Glassy
77 schema:givenName Mark C.
78 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005621065.14
79 rdf:type schema:Person
80 sg:person.0647155176.80 schema:affiliation https://www.grid.ac/institutes/grid.136304.3
81 schema:familyName Koda
82 schema:givenName Keiji
83 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647155176.80
84 rdf:type schema:Person
85 sg:person.0712131445.60 schema:affiliation https://www.grid.ac/institutes/grid.136304.3
86 schema:familyName Nakajima
87 schema:givenName Nobuyuki
88 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712131445.60
89 rdf:type schema:Person
90 sg:pub.10.1007/bf02052265 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028423483
91 https://doi.org/10.1007/bf02052265
92 rdf:type schema:CreativeWork
93 https://app.dimensions.ai/details/publication/pub.1077881267 schema:CreativeWork
94 https://app.dimensions.ai/details/publication/pub.1082807375 schema:CreativeWork
95 https://doi.org/10.1001/archsurg.1990.01410240073015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027477712
96 rdf:type schema:CreativeWork
97 https://doi.org/10.1007/bf02052265 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028423483
98 rdf:type schema:CreativeWork
99 https://doi.org/10.1073/pnas.80.20.6327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019673515
100 rdf:type schema:CreativeWork
101 https://www.grid.ac/institutes/grid.136304.3 schema:alternateName Chiba University
102 schema:name First Department of Surgery, Chiba University School of Medicine, 1-8-1 Inohana, Chuo-Ku 260, Japan
103 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...